Metformin Experience on Minimal Hepatic Encephalopathy
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Primary aim:
-To assess the effect of metformin use on the treatment of minimal hepatic encephalopathy in
patients with liver cirrhosis.
Secondary aim:
-To evaluate if metformin is a safety drug in patients showing liver cirrhosis.
Phase:
Phase 4
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla